MXPA00012685A - Oregano para el tratamiento de parasitos internos y protozoarios. - Google Patents

Oregano para el tratamiento de parasitos internos y protozoarios.

Info

Publication number
MXPA00012685A
MXPA00012685A MXPA00012685A MXPA00012685A MXPA00012685A MX PA00012685 A MXPA00012685 A MX PA00012685A MX PA00012685 A MXPA00012685 A MX PA00012685A MX PA00012685 A MXPA00012685 A MX PA00012685A MX PA00012685 A MXPA00012685 A MX PA00012685A
Authority
MX
Mexico
Prior art keywords
oregano
treatment
protozoa
internal parasites
parasites
Prior art date
Application number
MXPA00012685A
Other languages
English (en)
Inventor
Daryl L Deluca
Original Assignee
Biotics Res Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotics Res Corp filed Critical Biotics Res Corp
Publication of MXPA00012685A publication Critical patent/MXPA00012685A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/04Amoebicides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MXPA00012685A 1998-06-18 1999-06-16 Oregano para el tratamiento de parasitos internos y protozoarios. MXPA00012685A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/099,580 US5955086A (en) 1998-06-18 1998-06-18 Oregano for the treatment of internal parasites and protozoa
PCT/US1999/013497 WO1999065505A1 (en) 1998-06-18 1999-06-16 Oregano for the treatment of internal parasites and protozoa

Publications (1)

Publication Number Publication Date
MXPA00012685A true MXPA00012685A (es) 2003-09-10

Family

ID=22275684

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA00012685A MXPA00012685A (es) 1998-06-18 1999-06-16 Oregano para el tratamiento de parasitos internos y protozoarios.

Country Status (10)

Country Link
US (1) US5955086A (es)
EP (1) EP1089745B1 (es)
JP (1) JP4558200B2 (es)
AT (1) ATE274915T1 (es)
AU (1) AU741087B2 (es)
CA (1) CA2335485C (es)
DE (1) DE69919868T2 (es)
ES (1) ES2228057T3 (es)
MX (1) MXPA00012685A (es)
WO (1) WO1999065505A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1140027T3 (da) * 1998-12-23 2006-02-27 Alza Corp Doseringsformer indeholdende poröse partikler
US6342249B1 (en) 1998-12-23 2002-01-29 Alza Corporation Controlled release liquid active agent formulation dosage forms
US6414036B1 (en) 1999-09-01 2002-07-02 Van Beek Global/Ninkov Llc Composition for treatment of infections of humans and animals
US6579542B1 (en) * 2000-03-02 2003-06-17 Cecil Faulkner Treating feline-specific disorders by orally administering Hydrastis canadensis
ATE354956T1 (de) 2001-01-23 2006-03-15 Beek Global Llc Van Pestizide verbindungen und zusammensetzungen
US6884763B2 (en) 2001-10-30 2005-04-26 Permatex, Inc. Waterless hand cleaner containing plant derived natural essential oil
US7411005B2 (en) * 2002-02-13 2008-08-12 Van Beek Natural Science, Llc Compositions and methods for increasing milk production in animals
US7144590B2 (en) * 2003-01-09 2006-12-05 Lipoprotein Technologies, Inc. Bioactive compositions derived from humulus lupulus
US7125963B2 (en) * 2004-03-03 2006-10-24 En N Tech Inc Treatments for contaminant reduction in lactoferrin preparations and lactoferrin containing compositions
US8992999B2 (en) 2004-06-25 2015-03-31 Alltech, Inc. Methods and compositions for controlling parasitic infections of animals
EP1768491B1 (en) * 2004-07-21 2010-03-10 Alltech, Inc. Composition and its use for controlling protozoal infections of animals
US8119169B2 (en) 2004-12-28 2012-02-21 Colgate-Palmolive Company Oregano oral care compositions and methods of use thereof
US20080032021A1 (en) * 2006-05-19 2008-02-07 Faltys Gary L Feed supplements for ruminants including essential oil compounds and organic acids
US20090226549A1 (en) 2008-03-06 2009-09-10 Kenneth John Hughes Herbal extracts and flavor systems for oral products and methods of making the same
WO2011029077A2 (en) * 2009-09-04 2011-03-10 Sensient Flavors Llc Botanical extracts and flavor systems and methods of making and using the same
US20130101634A1 (en) * 2011-10-12 2013-04-25 Deerland Enzymes, Inc. Compositions and methods for reducing microbial overgrowth in the small intestines
GB201404505D0 (en) * 2013-09-06 2014-04-30 Mars Inc Oral anti-parasitic composition
US9913478B2 (en) * 2013-12-02 2018-03-13 Arrowhead Center, Inc. Organic and environmentally “green” biocide compositions and applications
JP6372158B2 (ja) * 2014-05-15 2018-08-15 住友ベークライト株式会社 食品包装用シート、食品包装容器および食品包装体
GR20180100568A (el) * 2018-12-27 2020-07-16 Μαριανα Γεωργιου Χατζαρα Συνθεση με βαση το δικταμο κατα του βακτηριου ακανθαμοεμπα που προσβαλλει τους οφθαλμους

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ308661A (en) * 1995-05-26 1999-07-29 Ropapharm Bv Pharmaceutical compositions, based on etheric oils obtained from plants for use in the human and veterinary medical field
GR1002451B (el) * 1995-06-29 1996-10-14 ������ �. Αντιφλεγμονωδεις συνθεσεις που εχουν ως βαση ενεργα συστατικα ορισμενων βοτανων χρησιμοποιουμενες για σκοπους ιατρικους και κτηνιατρικους, και μεθοδοι παρασκευης φαρμακων και σκευασματων για τους παραπανω σκοπους.

Also Published As

Publication number Publication date
DE69919868D1 (de) 2004-10-07
DE69919868T2 (de) 2005-08-25
AU4442099A (en) 2000-01-05
CA2335485A1 (en) 1999-12-23
ES2228057T3 (es) 2005-04-01
JP2002518338A (ja) 2002-06-25
AU741087B2 (en) 2001-11-22
EP1089745A1 (en) 2001-04-11
JP4558200B2 (ja) 2010-10-06
US5955086A (en) 1999-09-21
EP1089745A4 (en) 2002-03-20
EP1089745B1 (en) 2004-09-01
WO1999065505A1 (en) 1999-12-23
ATE274915T1 (de) 2004-09-15
CA2335485C (en) 2008-12-02

Similar Documents

Publication Publication Date Title
EP1089745A4 (en) OREGANO FOR TREATING INTERNAL PARASITES AND PROTOZOES
WO2003088897A3 (en) Fab i inhibitors
AR062713A2 (es) Emulsion antimicrobiana
CA96336S (en) Cooler
AU2002365972A1 (en) Tampon with an overwrap or overwraps having both masking and wicking properties
MY135732A (en) 5,6-trimethylenepyrimidin - 4 - one compounds
TR200202194T2 (tr) Poliglütamik asit-kamptotesin birleşikleri ve hazırlama yöntemleri
BR0215405A (pt) Composições e processos de uso de collajolie
AU2001262348A1 (en) Lateral semiconductor device with low on-resistance and method of making the same
AU2003291227A8 (en) Antibacterial agents
SG148031A1 (en) Use of cci-779 as an antineoplastic agent
WO2001056466A3 (en) Method for evaluating novel stroke treatments using a tissue risk map
TR200002759T2 (tr) Bacak uyuşması sendromunun tedavisinde kabergolin kullanımı.
EP1560821B8 (en) Antibacterial agents
GB2377328A (en) Integrated circuit having various operational modes and a method therefor
NO20031860L (no) Kahalalid F
WO2001040473A3 (en) Pseudomonas aeruginosa antigens
NZ509051A (en) Chemotaxis-inhibiting protein of staphylococcus (CHIPS) and its use
ATE425246T1 (de) Hydrophile zusammensetzung, die eine von vibrio proteolyticus hergestellte protease enthält
SE0302361D0 (sv) Inhibering av upptagning av monoamin
TR200002939T2 (tr) Paroksetin maleat
ATE189460T1 (de) Gegen protozoen wirksamezyklische tetrapeptide
PT1274426E (pt) Uso de tioamida-oxazolidinonas no tratamento da reabsorcao ossea e da osteoporose
BR9914722A (pt) Derivados de anticonvulsivo úteis no tratamento de dependência, vìcio e abuso do álcool
AU2001280093A1 (en) Method for the prevention and treatment of retinopathy

Legal Events

Date Code Title Description
FG Grant or registration